DQSA: New regs give FDA broader powers over compounding

JUN 10, 2014

 

By: Monica Shah, PharmD

Sometimes it takes a significant crisis to forge the adoption of appropriate government regulations. Passed last November, the Drug Quality and Security Act (DQSA) is a direct response to the aftermath of the devastating fungal meningitis outbreak linked to the New England Compounding Center (NECC). The legislation, intended to regulate compounding pharmacies and establish a track-and-trace pedigree system for drugs, has engendered a sigh of relief in some patient-safety circles

continue to read here